SFMG Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Sell |
4,633
-2,905
| -39% | -$1.29M | 0.15% | 70 |
|
|
2025
Q1 | $3.65M | Sell |
7,538
-111
| -1% | -$53.8K | 0.29% | 47 |
|
|
2024
Q4 | $3.08M | Sell |
7,649
-96
| -1% | -$38.7K | 0.24% | 53 |
|
|
2024
Q3 | $3.6M | Sell |
7,745
-100
| -1% | -$46.5K | 0.29% | 43 |
|
|
2024
Q2 | $3.68M | Buy |
7,845
+60
| +0.8% | +$28.1K | 0.32% | 43 |
|
|
2024
Q1 | $3.25M | Buy |
7,785
+64
| +0.8% | +$26.8K | 0.28% | 50 |
|
|
2023
Q4 | $3.14M | Buy |
7,721
+982
| +15% | +$400K | 0.29% | 45 |
|
|
2023
Q3 | $2.34M | Sell |
6,739
-1,970
| -23% | -$685K | 0.24% | 56 |
|
|
2023
Q2 | $3.06M | Sell |
8,709
-21
| -0.2% | -$7.39K | 0.32% | 44 |
|
|
2023
Q1 | $2.75M | Buy |
8,730
+15
| +0.2% | +$4.73K | 0.3% | 49 |
|
|
2022
Q4 | $2.52M | Hold |
8,715
| – | – | 0.28% | 55 |
|
|
2022
Q3 | $2.53M | Hold |
8,715
| – | – | 0.3% | 47 |
|
|
2022
Q2 | $2.46M | Sell |
8,715
-193
| -2% | -$54.4K | 0.28% | 51 |
|
|
2022
Q1 | $2.33M | Sell |
8,908
-72
| -0.8% | -$18.8K | 0.23% | 58 |
|
|
2021
Q4 | $1.97M | Buy |
8,980
+1,070
| +14% | +$235K | 0.19% | 68 |
|
|
2021
Q3 | $1.44M | Sell |
7,910
-110
| -1% | -$20K | 0.16% | 75 |
|
|
2021
Q2 | $1.62M | Buy |
8,020
+1,950
| +32% | +$393K | 0.18% | 65 |
|
|
2021
Q1 | $1.3M | Buy |
6,070
+1,180
| +24% | +$253K | 0.15% | 71 |
|
|
2020
Q4 | $1.16M | Buy |
+4,890
| New | +$1.16M | 0.15% | 70 |
|